CLINICAL_TRIALS
trial_result
· 2016-07-07
Clinical Trial Update: Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes [Phase 1]
Summary
A Phase 1 study evaluating the acute metabolic effects of exenatide in Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED